Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population ‐based study among older breast cancer patients

CONCLUSIONSAdjuvant chemotherapy is associated with a small but significant increase in the risk of AML and MDS, especially with regimens that include A. Longer follow‐up is needed to confirm that risk is not increased with the recently adopted TC regimen. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - December 14, 2017 Category: Cancer & Oncology Authors: Aron S. Rosenstock, Jiangong Niu, Sharon H. Giordano, Hui Zhao, Antonio C. Wolff, Mariana Chavez ‐MacGregor Tags: Original Article Source Type: research